OTOLOGICS
US firm OTOlogics is banking on the Côte d'Azur for the European deployment of the first fully implantable hearing device. Its Sophia Antipolis R&D center is expected to create some twenty jobs over the next
three years."The Côte d'Azur is undoubtedly the most attractive inward investment destination in France. The factors that carried the most weight with OTOlogics when reaching its decision were the proximity to an inexhaustible pool of competencies, and the presence of two major competitive clusters. It is no accident that so many active implant manufacturers, like Austria's Med-El, have been relocating here for years."
Laurent Badih, CEO, OTOlogics France
www.otologics.com
The Côte d'Azur boasts international success stories in pharmaceuticals, medical instruments, imagery, biomedical technologies, veterinary medicine and agronomy. Today, it is home to innovative science clusters in ophthalmology, oncology and neurology.
The Côte d'Azur offers life sciences companies an unparalleled scientific and industrial setting. It is one of the few regions in the world with so much expertise in both the health sector and IT technologies.
With a wealth of talent in areas as diverse as the pharmaceutical industry, medical instruments, imaging, biomedical technologies, the veterinary industry and agronomics, companies find it easy to hire top engineers and researchers.
Some 2,000 researchers are based here at leading private and French state-run research institutes.
- The Nice Teaching Hospital is the
largest hospital development project
underway in France. The new facility
will usher in a new generation of
research and public health hospitals
and will make space available to
private research teams.
- The Head and Neck Cancer Institute
is a leading center in head and neck
oncology and surgery.
- The Institute of Molecular and
Cellular Pharmacology (IPCM) is
adding a new pavilion for Neurology
and Alzheimer's disease.
- The Claude Pompidou Foundation is
building a pilot center for healthcare,
research and prevention in Nice.
EUROBIOMED is one of France's 8 national
competitiveness clusters in health and biotechnologies. It brings together key players in the Provence-Alpes-Côte d'Azur and Languedoc-Roussillon regions to work on 5 main themes:
- Fight infectious, tropical and emergent diseases
- Fight rare and orphan diseases
- Medical tequipments: Biomarkers, diagnosis in vitro
- Immunology and its therapeutic applications
- The neurological pathologies, ageing and disability
Growth in the companion animals segment has been very steady and sales in the food producing animals segment have also increased strongly
Opened in 1998, the centre for cell culture in therapy, the first in Europe, is benefitting from an investment of € 3.5 million for its expansion.
Carros-based MDI’s compressed air vehicles will reinforce VU Log’s self-service electric car fleet in Antibes.
Top skills come together on the Côte d’Azur to create new, pioneering solutions for the fight against unbearable or chronic pain.
An innovative approach geared at boosting teleworking and creating new businesses: 3 questions to Virginie Fernandez, in charge of the teleincubator STARTEO
Bio
Annual turnover: 2.2 billion euros
Companies: 246
Jobs: 9,460
Fields of activity: Biotechnologies, Biomaterials, Chemistry, Cosmetology, Biomedical Engineering, Health Image and Software, Medical Instrumentation, Pharmaceutical & Veterinary Industrie, Pharmacology, Agronomy.
Leaders: Arkopharma, Asepta, Bayer Cropsciences, CLL Pharma, Dow Agrosciences, Galderma, IRIS Pharma, Integra Neurosciences Implants, Laboratoires Boiron, Laboratoires Genévrier, Lundbeck/Elaiapharm, MXM, NicOx, Skinethic, Txcell, Virbac
Success Stories: Iris Pharma, Median Technologies, Neomah, Neurelec, Nicox, Quantificare, Senseor, Virbac, Theralpha, Txcell, VenomeTech,...
Competitive Clusters : EUROBIOMED Biocluster